The COMPHACRISIS project explored the application of EU competition law enforcement in the pharmaceutical sector through seven structured work packages. In the initial planning stage (WP1), the project established a robust online presence, including X (Twitter) (@minacompetition), LinkedIn, Blue Sky and a dedicated project page on www.minahosseini.com/comphacrisis. WP2 focused on the pre-crisis period, offering an in-depth look at EU competition law enforcement in the pharmaceutical sector before COVID-19, examining critical cases and policies. In the Crisis phase (WP3), the MSCA fellow explored competition law enforcement during COVID-19, conducting nine semi-structured interviews with stakeholders, including EU officials, national competition authorities, academics, and industry experts (after obtaining ethical approval from the UCD Ethics Office). A key milestone was the first COMPHACRISIS international and interdisciplinary workshop hosted at UCD in September 2023. The post-crisis analysis (WP4) expanded the scope to cover EU post-pandemic initiatives, including the new EU compulsory licensing proposal, the new EU pharmaceutical reform package, and the implications of the EU AI Act on healthcare. The researcher presented WP 2, WP3 and WP4 findings at seven international conferences, including the University Association for Contemporary European Studies Annual Conference (UACES 2023 & 2024) and the Society of Legal Scholars Annual Conference ( SLS 2023). She also delivered 15 guest lectures at prestigious institutions such as Fordham University, Università di Bologna, Queen's University Belfast and Instituto Brasileiro de Concorrência eInovação. The MSCA fellow published three peer-reviewed articles (in the Journal of Antitrust Enforcement, Competition Policy International, and Irish Studies in International Affairs), four forthcoming book chapters, two upcoming journal articles, and several blog posts. Additionally, the researcher organised four webinars for UCD students, postdocs, and potential applicants for grant writing and MSCA fellowships. In September 2024, she held the second workshop, "Healthcare at the Crossroads," at UCD. Throughout the project, the researcher undertook an extensive training program (WP6) covering advanced research methods, project management (achieving QQI certification with distinction), research integrity and teaching and learning. WP7 handled project management, ensuring efficient administration, documentation, and compliance with reporting requirements (including submitting three reports on career development, data management and communication). Additionally, a special symposium issue in the Journal of Law, Medicine & Ethics, stemming from the project's findings, is forthcoming in 2025. The project's outcomes are widely shared through policy recommendations, publications, the Zenodo COMPHACRISIS community and open-access channels. Social media engagement (3+ posts weekly across platforms) and research data sharing via Zenodo have sustained the project's visibility.
